Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
The European Journal of Health Economics
Published in: The European Journal of Health Economics 8/2017

01-11-2017 | Original Paper

Costs of dementia in the Czech Republic

Authors: Iva Holmerová, Jakub Hort, Robert Rusina, Anders Wimo, Michal Šteffl

Published in: The European Journal of Health Economics | Issue 8/2017

Login to get access

Abstract

Objective

The aim of this study was to estimate the cost of dementia in the Czech Republic.

Methods

One hundred and nineteen patient-caregiver dyads participated in our multicenter observational cost-of-illness study. The modified Resource Utilization in Dementia Questionnaire was used as the main tool to collect data from patients and caregivers. Medical specialists provided additional data from medical records. The average costs of dementia were calculated and patients were then divided by the level of cognitive impairment. A generalized linear model was used to determine if differences were present for selected cost variables.

Results

The mean (standard deviation) for direct cost per a patient in a month was estimated to be €243.0 (138.0), €1727.1 (1075.6) for the indirect cost, and €1970.0 (1090.3) for the total cost of dementia in the Czech Republic. All of the costs increased as dementia severity increased. Both the indirect and total costs significantly (p < 0.05) increased if patients were living with their primary caregiver, and if the severity of cognitive impairment was increased.

Conclusions

The indirect cost, which was represented mainly by informal care, comprised the main part of the total cost of care for patients with dementia in the Czech Republic. Both total and indirect care costs increased significantly the cognition declined.
Literature
1.
EC: Long-term care in ageing societies—Challenges and policy options. European Commission, Brussels (2013)
2.
AE: Alzheimer Europe 2013 yearbook with a focus on national policies relating to the care and support of people with dementia and their carers, as well as the prevalence of dementia including the Alzheimer Europe Annual Report 2012. Alzheimer Europe, Luxembourg (2013)
3.
EC: Communication from the Commission to the European Parliament and Council on a European initiative on Alzheimer’s disease and other dementias. European Commission, Brussels (2009)
4.
EC: Identifying fiscal sustainability challenges in the areas of pension, health care and long-term care policies. European Commission, Brussels (2014)
5.
ADI: World Alzheimer Report 2015. Alzheimer´s Disease International, London (2015)
6.
WHO/ADI: Dementia: a public health priority. World Health Organization, Geneva (2012)
7.
AE: Dementia in Europe—Yearbook 2008 with a focus on social support, socio-economic cost, psycho-social interventions and prevention. Gove, D., Georges, J., (eds.). Alzheimer Europe, Luxembourg 2009
8.
9.
Mátl, O., Holmerová, I., Mátlová, M.: Zpráva o stavu demence 2014. Praha, Česká alzheimerovská společnost (2014)
10.
Mátl, O., Holmerova, I., Mátlová, M.: Analytický doplněk ke Zprávě o stavu demence 2014. Praha, Česká alzheimerovská společnost (2014)
11.
12.
Wimo, A., Gustavsson, A., Jonsson, L., Winblad, B., Hsu, M.A., Gannon, B.: Application of resource utilization in dementia (RUD) instrument in a global setting. Alzheimers Dement. (2013). doi:10.​1016/​j.​jalz.​2012.​06.​008
13.
Mauskopf, J., Racketa, J., Sherrill, E.: Alzheimer’s disease: the strength of association of costs with different measures of disease severity. J. Nutr. Health Aging. 14(8), 655–663 (2010)CrossRefPubMed
14.
Costa, N., Ferlicoq, L., Derumeaux-Burel, H., Rapp, T., Garnault, V., Gillette-Guyonnet, S., et al.: Comparison of informal care time and costs in different age-related dementias: a review. Biomed. Res. Int. (2013). doi:10.​1155/​2013/​852368
15.
Crum, R.M., Anthony, J.C., Bassett, S.S., Folstein, M.F.: Population-based norms for the mini-mental state examination by age and educational level. JAMA 269(18), 2386–2391 (1993)CrossRefPubMed
16.
EC: Evidence on demographic and social trends social policies’ contribution to inclusion, employment and the economy. Brussels (2013)
17.
Franková, V., Holmerova, I., Horinek, D., Jirák, R., Vyhnálek, M.: Alzheimerova demence v praxi. Konsenzus psychiatricko-neurologicko-geriatrický. Praha, Mladá fronta (2011)
18.
Vyhnalek, M., Bartos, A., Dostál, V., Franková, V., Holmerova, I., Laczo, J., et al.: Diagnostikujeme a léčíme demence správně a včas Výsledky průzkumu ve světle nových doporučení. Neurol prax. 12, 342–346 (2011)
19.
Ressner, P., Hock, C., Rektorova, I., Bartos, A., Rusina, R., Linek, V., et al.: Doporučené postupy pro diagnostiku Alzheimerovy choroby a dalších onemocnění spojených s demencí. Cesk. Slov. Neurol. N. 71/104(4), 494–501 (2008)
20.
Sheardova, K., Hort, J., Rusina, R., Bartos, A., Linek, V., Ressner, P., et al.: Doporučené postupy pro léčbu Alzheimerovy nemoci a dalších onemocnění spojených s demencí. Cesk. Slov. Neurol. N. 70/103(5), 589–594 (2007)
21.
Salvi, F., Miller, M.D., Grilli, A., Giorgi, R., Towers, A.L., Morichi, V., et al.: A manual of guidelines to score the modified cumulative illness rating scale and its validation in acute hospitalized elderly patients. J. Am. Geriatr. Soc. (2008). doi:10.​1111/​j.​1532-5415.​2008.​01935.​x
22.
Lopez-Pousa, S., Garre-Olmo, J., Turon-Estrada, A., Hernandez, F., Exposito, I., Lozano-Gallego, M., et al.: Cost relation between severity of Alzheimer’s disease and cognitive and functional impairment. Med. Clin. (Barc) 122(20), 767–772 (2004)CrossRef
23.
Víšek, P., Prusa, L.: Optimalizace sociálních služeb. Výzkumný ústav práce a sociálních věcí, v.v.i, Praha (2012)
24.
UZIS: Zdravotnická ročenka České republiky 2012. Ústav zdravotnických informací a statistiky, Praha (2013)
25.
Nechanská, B.: Health care of patients treated for dementia in out-patient and in-patient facilities in the Czech Republic in 2008–2012. Praha, Ústav zdravotnických informací a statistiky (2013)
26.
EC: Investing in health. European Commission, Brussels (2013)
27.
Hux, M.J., O’Brien, B.J., Iskedjian, M., Goeree, R., Gagnon, M., Gauthier, S.: Relation between severity of Alzheimer’s disease and costs of caring. CMAJ 159(5), 457–465 (1998)PubMedPubMedCentral
28.
29.
Max, W., Webber, P., Fox, P.: Alzheimer’s disease. The unpaid burden of caring. J. Aging Health 7(2), 179–199 (1995)CrossRefPubMed
30.
Rice, D.P., Fox, P.J., Max, W., Webber, P.A., Lindeman, D.A., Hauck, W.W., Segura, E.: The economic burden of Alzheimer’s disease care. Health Aff. (Millwood) 12(2), 164–176 (1993)CrossRef
31.
Rigaud, A.S., Fagnani, F., Bayle, C., Latour, F., Traykov, L., Forette, F.: Patients with Alzheimer’s disease living at home in France: costs and consequences of the disease. J. Geriatr. Psychiatry Neurol. 16(3), 140–145 (2003)CrossRefPubMed
32.
Boada, M., Pena-Casanova, J., Bermejo, F., Guillen, F., Hart, W.M., Espinosa, C., Rovira, J.: Costs of health care resources of ambulatory-care patients diagnosed with Alzheimer’s disease in Spain. Med. Clin. (Barc) 113(18), 690–695 (1999)
33.
Jonsson, L., Eriksdotter Jonhagen, M., Kilander, L., Soininen, H., Hallikainen, M., Waldemar, G., et al.: Determinants of costs of care for patients with Alzheimer’s disease. Int. J. Geriatr. Psychiatry (2006). doi:10.​1002/​gps.​1489
34.
Darba, J., Kaskens, L., Lacey, L.: Relationship between global severity of patients with Alzheimer’s disease and costs of care in Spain; results from the co-dependence study in Spain. Eur. J. Health Econ. (2014). doi:10.​1007/​s10198-014-0642-0 PubMed
35.
Trávníčková, K.: Ekonomická analýza nákladů na léčbu a péči o pacienty s Alzheimerovou chorobou v ČR- Economical evaluation of Alzheimer´s disease in the Czech Republic. Praha, České vysoké učení technické (2013)
Metadata
Title
Costs of dementia in the Czech Republic
Authors
Iva Holmerová
Jakub Hort
Robert Rusina
Anders Wimo
Michal Šteffl
Publication date
01-11-2017
Publisher
Springer Berlin Heidelberg
Published in
The European Journal of Health Economics / Issue 8/2017
Print ISSN: 1618-7598
Electronic ISSN: 1618-7601
DOI
https://doi.org/10.1007/s10198-016-0842-x

Other articles of this Issue 8/2017

The European Journal of Health Economics 8/2017 Go to the issue

Original Paper

The place of DPP-4 inhibitors in the treatment algorithm of diabetes type 2: a systematic review of cost-effectiveness studies

Editorial

Market approval for drugs in the EU: time to change direction?

Original Paper

Head-to-head comparison of health-state values derived by a probabilistic choice model and scores on a visual analogue scale

Original Paper

Junior doctors’ medical specialty and practice location choice: simulating policies to overcome regional inequalities

Original Paper

Cost effects of preterm birth: a comparison of health care costs associated with early preterm, late preterm, and full-term birth in the first 3 years after birth

Original Paper

The impact of minimum wages on population health: evidence from 24 OECD countries